These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9160516

  • 1. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.
    Nakamura Y, Kameoka M, Tobiume M, Kaya M, Ohki K, Yamada T, Ikuta K.
    Vaccine; 1997 Apr; 15(5):489-96. PubMed ID: 9160516
    [Abstract] [Full Text] [Related]

  • 2. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
    Nishino Y, Kameoka M, Okada Y, Zhong Q, Kimura T, Azuma I, Ikuta K.
    Vaccine; 1994 May; 12(6):485-91. PubMed ID: 7913566
    [Abstract] [Full Text] [Related]

  • 3. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
    Buseyne F, McChesney M, Porrot F, Kovarik S, Guy B, Rivière Y.
    J Virol; 1993 Feb; 67(2):694-702. PubMed ID: 7678303
    [Abstract] [Full Text] [Related]

  • 4. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
    van Baalen CA, Klein MR, Huisman RC, Dings ME, Kerkhof Garde SR, Geretti AM, Gruters R, van Els CA, Miedema F, Osterhaus AD.
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1659-65. PubMed ID: 8760412
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M, Chen M, Arichi T, Masaki T, Nishioka M, Newman M, Nakazawa T, Feinstone SM, Berzofsky JA.
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA.
    Biotechnol Ther; 1991 Jan; 2(1-2):123-35. PubMed ID: 1726961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice.
    Yoshizawa I, Mizuochi T, Ogata A, Murakami M, Yagita H, Takahashi Y, Mizuochi T, Takemori T, Tsunetsugu-Yokota Y.
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):469-79. PubMed ID: 12882656
    [Abstract] [Full Text] [Related]

  • 15. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G, Kostyu DD, Cox J, Dawson DV, Flores J, Weinhold KJ, Osmanov S.
    AIDS Res Hum Retroviruses; 2000 Sep 20; 16(14):1433-43. PubMed ID: 11018863
    [Abstract] [Full Text] [Related]

  • 16. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 20; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 17. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a noncovalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response.
    Nehete PN, Arlinghaus RB, Sastry KJ.
    Viral Immunol; 1994 Mar 20; 7(4):189-97. PubMed ID: 7576033
    [Abstract] [Full Text] [Related]

  • 18. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P, Ali S, Sharan R, Lacey SF, La Rosa C, Longmate J, Buck C, Siliciano RF, Diamond DJ.
    J Immunol; 2003 Oct 15; 171(8):4028-39. PubMed ID: 14530323
    [Abstract] [Full Text] [Related]

  • 19. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.
    J Immunol; 2004 May 01; 172(9):5249-61. PubMed ID: 15100263
    [Abstract] [Full Text] [Related]

  • 20. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.
    J Virol; 2004 Feb 01; 78(3):1324-32. PubMed ID: 14722287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.